logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
C

Claire Harrison

Guy's and St Thomas' NHS Foundation Trust

80H指数
849论文数
3.5W被引数
收录论文 164
发表时间
logo
Allele burden expansion in JAK2V617F and CALR-mutated myeloproliferative neoplasms predicts disease progression and is associated with anagrelide treatmentJAK2V617F和CALR突变骨髓增殖性肿瘤中的等位基因负荷扩增预测疾病进展并与安归那治疗相关
errHemaSphere
IF14.6
err2026-09-01
err0
errOAAI
errZi Yun Ng; Laurane Cottin; Marine Demoy; Damien Luque Paz; Corentin Orvain; Wayne-Corentin Lambert; Jean-Christophe Ianotto; Eric Lippert; David M. Ross; Diana Iarossi; Alesia Khan; Daniel Lock; Catherine Truong; Kamel Laribi; Yun Fan Yang; Laura Li Gagnon; Valerie Ugo; Claire N. Harrison; Jennifer O'Sullivan
err分享
err收藏
A phase 1 study of VAC85135, a neoantigen vaccine regimen targeting calreticulin and JAK2 mutations, in combination with ipilimumab in patients with myeloproliferative neoplasmsVAC85135（一种靶向钙网蛋白和JAK2突变的 neoantigen 疫苗方案）联合伊匹木单抗在骨髓增殖性肿瘤患者中的1期研究
errCancer Immunology Immunotherapy
IF5.1
err2026-08-24
err0
errOAAI
errSalman Otoukesh; Bethan Psaila; Andrew Kuykendall; Aaron T. Gerds; Ahmed Abdulgawad; Prithviraj Bose; Charlotte Van Bogaert; Jennifer Bishop; Patrick Wilkinson; Baolian Liu; Tianxiang Kevin Han; Busola Sanusi; Jaymala Patel; Katelyn D. Miller; Denis Smirnov; John T. Loffredo; M. Alejandro Sepulveda; Ricardo Attar; Kim Staquet; Charles G. Drake; Nikki Daskalakis; Claire Harrison
err分享
err收藏
Integrating novel therapeutic strategies in myeloproliferative neoplasms: Driving disease-directed progress整合新型治疗策略在骨髓增殖性肿瘤中的应用：推动疾病导向的进展
errBritish Journal of Haematology
IF3.8
err2026-08-20
err0
errOAAI
errTrung Q. Ngo; Maria Georgiou; Donal P. McLornan; Claire N. Harrison
err分享
err收藏
Ruxolitinib treatment in patients with polycythemia vera reduces JAK2 variant allele frequency and improves symptom burden and hematocrit control鲁索利替尼治疗真性红细胞增多症患者的JAK2变异等位基因频率，并改善症状负担和血细胞比容控制。
errTherapeutic Advances in Hematology
IF3.1
err2026-03-24
err0
PREAI
errClaire N. Harrison; Jean-Jacques Kiladjian; J. E. Hamer-Maansson; Ahmad Naim; Francesca Palandri; Francesco Passamonti
err分享
err收藏
Common Themes and Uncertainties in Management of Secondary Polycythaemia: An International Clinician Survey of Practice继发性红细胞增多症管理的共同主题与不确定性：一项国际临床医生实践调查
erreJHaem
IF0
err2025-12-01
err2
errOAAI
errNicolson, Phillip L. R.; Asif, Midhat; Buka, Richard J.; Dyer, Peter; Hassan, Eman; Harrison, Claire N.; Maybury, Bernard D.; Doyle, Andrew J.
err分享
err收藏
Investigation and management of thrombocytosis without JAK2, CALR or MPL mutations: A British Society for Haematology Guideline无JAK2、CALR或MPL突变性血小板增多症的检查与管理：英国血液学标准化委员会指南
errBRITISH JOURNAL OF HAEMATOLOGY
IF3.8
err2025-12-01
err0
errOAAI
errGodfrey, Anna L.; Khan, Alesia A.; McGregor, Andrew; Innes, Andrew J.; Altohami, Mohammed; Cross, Nicholas C. P.; Frewin, Rebecca; Garg, Mamta; Green, Anna; Grinfeld, Jacob; McLornan, Donal P.; Wilson, Andrew J.; Harrison, Claire N.; Mead, Adam J.; Nangalia, Jyoti
err分享
err收藏
European LeukemiaNet criteria for safety and efficacy evaluation of new drugs for myelofibrosis欧洲白血病网络联盟（European LeukemiaNet）关于新药在骨髓纤维化中安全性和有效性评估的标准
errBlood Cancer Journal
IF11.6
err2025-11-24
err0
errOAAI
errMonia Marchetti; Alessandro Maria Vannucchi; John O. Mascarenhas; Alberto Alvarez-Larran; Prithviraj Bose; Robert Peter Gale; Claire Harrison; Rűdiger Hehlmann; Jean-Jacques Kiladjian; Steffen Koschmieder; Ruben Mesa; Francesco Passamonti; Alessandro Rambaldi; Ayalew Tefferi; Tiziano Barbui
err分享
err收藏
Genome-wide analysis defines genetic determinants of MPN subtypes and identifies a sex-specific association at CDH22/CD40全基因组分析确定了MPN亚型的遗传决定因素，并识别了CDH22/CD40位点的性别特异性关联。
errBlood
IF23.1
err2025-10-03
err0
PREAI
errWilliam J Tapper; Ahmed A Z Dawoud; Joannah Score; Andrew J Chase; E Joanna Baxter; Joanne Ewing; Louise Wallis; Paola Guglielmelli; Dolors Colomer; Beatriz Bellosillo; Montse Gomez; Juan Carlos Hernández-Boluda; Carlos Besses; Francisco Cervantes; Steffen Koschmieder; Anthony R Green; Andreas Reiter; Alessandro Vannucchi; Claire Harrison; Nicholas C P Cross
err分享
err收藏
Mesenchymal stromal cells from JAK2V617F myeloproliferative neoplasms support healthy and malignant hematopoiesis in a humanized scaffold model in vivoJAK2V617F骨髓增殖性肿瘤来源的间充质基质细胞在体内人源化支架模型中支持健康和恶性造血
errHemaSphere
IF14.6
err2025-08-22
err0
errOAAI
errAlessandra Ferrelli; Syed Mian; Marion Piganeau; Hector Huerga Encabo; Despoina Papazoglou; Giuseppe D'Agostino; Fatihah Mohamad Nor; Manuel Garcia-Albornoz; Steven Ngo; Linda Ariza-McNaughton; Erika Morsia; Matteo Giovanni Della Porta; Claire Harrison; Shahram Kordasti; Dominique Bonnet
err分享
err收藏
QRISK3 score is predictive of thrombotic risk in patients with myeloproliferative neoplasmsQRISK3评分可预测骨髓增殖性肿瘤患者的血栓风险
errLeukemia
IF13.4
err2025-07-24
err0
errOAAI
errAndrea Duminuco; Raj Vaghela; Sukhraj Virdee; Claire Woodley; Susan Asirvatham; Natalia Curto-Garcia; Priya Sriskandarajah; Jennifer O’Sullivan; Hugues de Lavallade; Deepti Radia; Shahram Kordasti; Giuseppe A. Palumbo; Claire Harrison; Patrick Harrington
err分享
err收藏
Clinical outcomes of high-risk patients with polycythemia vera after suboptimal response to first-line therapy who switched to ruxolitinib versus nonswitchers: results from the PV-Switch study真性红细胞增多症高风险患者在接受一线治疗效果不佳后切换至鲁索利替尼治疗与非切换者的临床结局比较：PV-Switch研究的结果
errTherapeutic Advances in Hematology
IF3.1
err2025-07-04
err0
errOAAI
errSteffen Koschmieder; Clemens Schulte; Eyck von der Heyde; Lambert Busque; Françoise Boyer-Perrard; Timothy Devos; Francesco Passamonti; Wendy Y. Cheng; Mu Cheng; Marja Nuortti; Volker Baum; Claire Harrison
err分享
err收藏
ADORE: an open platform study of ruxolitinib in combination with other novel therapies in patients with myelofibrosisADORE：一项关于鲁索利替尼与其他新型疗法联合治疗骨髓纤维化患者的开放平台研究
errBlood Advances
IF7.1
err2025-05-09
err0
errOAAI
errDavid M. Ross; Florian H. Heidel; Andrew Charles Perkins; Andreas Reiter; Carl Crodel; Caroline Riley; María Teresa Gómez-Casares; Istvan Takacs; Heiko Becker; Thomas Lehmann; Olga Vinogradova; Kate Burbury; Alessandro M. Vannucchi; Vikas Gupta; Marielle Wondergem; Jean-Jacques Kiladjian; Grace Cleary; Angela Zhang; Jagannath Kota; Anirudh Prahallad; Monika Wroclawska; Min Lu; Claire N. Harrison
err分享
err收藏
Polycythaemia vera
errNature Reviews Disease Primers
IF60.6
err2025-04-17
err0
PREAI
errHarrison, Claire N.; Barbui, Tiziano; Bose, Prithviraj; Kiladjian, Jean-Jacques; Mascarenhas, John; McMullin, Mary Frances; Mesa, Ruben; Vannucchi, Alessandro M.
err分享
err收藏
Pelabresib plus ruxolitinib for JAK inhibitor-naive myelofibrosis: a randomized phase 3 trialPelabresib联合ruxolitinib治疗JAK抑制剂初治骨髓纤维化：一项随机III期试验
errNATURE MEDICINE
IF50
err2025-03-10
err2
errOAAI
errRampal, Raajit K.; Grosicki, Sebastian; Chraniuk, Dominik; Abruzzese, Elisabetta; Bose, Prithviraj; Gerds, Aaron T.; Vannucchi, Alessandro M.; Palandri, Francesca; Lee, Sung-Eun; Gupta, Vikas; Lucchesi, Alessandro; Oh, Stephen T.; Kuykendall, Andrew T.; Patriarca, Andrea; alvarez-Larran, Alberto; Mesa, Ruben; Kiladjian, Jean-Jacques; Talpaz, Moshe; Scandura, Joseph M.; Lavie, David; Harris, Morgan; Kays, Sarah-Katharina; Li, Qing; Boxhammer, Rainer; Brown, Barbara; Jegg, Anna-Maria; Harrison, Claire N.; Mascarenhas, John
err分享
err收藏
Improvement in Serum Albumin As a Measure of Improved Metabolic Profile in Pacritinib-Treated Patients: A Retrospective Analysis of Patients Treated across Three Clinical Trials血清白蛋白改善作为Pacritinib治疗患者代谢状况改善的指标：一项回顾性分析，研究对象为接受三项临床试验治疗的患者的数据。
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errPalandri, Francesca; Sobas, Marta; Harrison, Claire; Rampal, Raajit; Buckley, Sarah; Suthar, Purvi; Roman-Torres, Karisse; Mascarenhas, John O.
err分享
err收藏
Imetelstat Versus Best Available Therapy in Patients with Intermediate-2 or High-Risk Myelofibrosis Relapsed or Refractory to Janus Kinase Inhibitor in IMpactMF, a Randomized, Open-Label, Phase 3 Trial伊美特尔stat 与最佳可用疗法在 IMpactMF 随机、开放标签、III 期试验中对接受过或难治于 Janus 激酶抑制剂的中间-2 或高风险骨髓纤维化患者中的比较
errBLOOD
IF23.1
err2024-11-05
err3
PREAI
errMascarenhas, John O.; Harrison, Claire; Bose, Prithviraj; Kiladjian, Jean-Jacques; Lucchesi, Alessandro; Vannucchi, Alessandro Maria; Berry, Tymara; Riggs, Jennifer; Peng, Lixian; Huang, Fei; Wan, Ying; Rodolf, Vivian; Ho, Judy; Navada, Shyamala; Komrokji, Rami S.
err分享
err收藏
RUX-AZA Response in AP/BP-MPN Is Driven By Release of the Differentiation Block in Mutant HSPCs: A Single-Cell Multi-Omic Analysis of Responders on the Phase Ib Phazar StudyRUX-AZA对AP/BP-MPN的响应由突变HSPCs的分化阻滞释放驱动：一项对Phazar Ib期研究中响应者的单细胞多组学分析
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errBrierley, Charlotte K.; Gaskell, Charlotte; Harrison, Claire; Yap, Christina; Jackson, Aimee; Byrne, Jennifer; Hamblin, Angela; Clark, Sally-Ann; Sullivan, Jennifer O.; Rodriguez-Meira, Alba; Murphy, Lauren; Clarke, Fiona Jane; Narayanan, Srinivasan; Bowen, David T.; Gudgin, Emma; Milojkovic, Dragana; Collings, Rebecca; Psaila, Bethan; Knapper, Steve; Drummond, Mark W.; Mead, Adam J.
err分享
err收藏
Clinical Relevance of the Integrative Analysis of Gut Microbiome and Metabolomics in Myeloid Neoplasms: Correlations with Genomic Profiles, Treatment Response/Complications and Clinical Outcome整合肠道微生物组与代谢组学分析在髓系肿瘤中的临床意义：与基因组特征、治疗反应/并发症及临床结局的关联
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errCampagna, Alessia; Clasen, Frederick; Portlock, Theo; Zampini, Matteo; Ficara, Francesca; Crisafulli, Laura; Brindisi, Matteo; Martano, Giuseppe; Saba, Elena; Ubezio, Marta; Russo, Antonio; Todisco, Gabriele; Maggioni, Giulia; Lanino, Luca; Buizza, Alessandro; Pinocchio, Nicole; Ventura, Denise; Viviani, Filippo; Torre, Elena; Dos Reis, Rita Antunes; Rocchi, Ettore; Castellani, Gastone; Uhlen, Mathias; Harrison, Claire; Kordasti, Shahram; Della Porta, Matteo Giovanni; Shoaie, Saeed
err分享
err收藏
Real World Efficacy and Safety of Momelotinib for Myelofibrosis: Evaluation of a UK-Wide Study Confirms 40% Anaemia Response Rate in a Non-Clinical Trial Cohort真实世界中Momelotinib治疗骨髓纤维化的疗效与安全性：一项英国全国性研究的评估证实了在非临床试验队列中40%的贫血缓解率
errBLOOD
IF23.1
err2024-11-05
err2
PREAI
errRampotas, Alexandros; Torre, Elena; Carter-Brzezinski, Luke; Duminuco, Andrea; Cadman-Davies, Llywelyn; Chee, Ashlyn; Panitsas, Fotios; Alimam, Samah; Milojkovic, Dragana; Kaczmarski, Richard; Fraser, Louise; Frewin, Rebecca; Foley, Kate; Hockings, Catherine; Khan, Alesia; Williams, Rhys; Ryan, Jennifer; Yip, Kawai; Thaw, Kyaw Htin; Sheikh, Amna; Wadelin, Frances; Godfrey, Anna L.; Teh, Chun Huat; Wilson, Andrew J.; Lambert, Jonathan; Mead, Adam J.; Mclornan, Donal P.; Innes, Andrew J.; Mcgregor, Andrew; Somervaille, Tim; Harrison, Claire; Harrington, Patrick; Psaila, Bethan
err分享
err收藏
A Phase 1/2 Study of Nuvisertib (TP-3654), an Investigational Selective PIM1 Kinase Inhibitor, in Combination with JAK Inhibitors Ruxolitinib or Momelotinib in Patients with Myelofibrosis一项关于Nuvisertib（TP-3654）的1/2期研究，Nuvisertib是一种实验性选择性PIM1激酶抑制剂，与JAK抑制剂Ruxolitinib或Momelotinib联合用于骨髓纤维化患者。
errBLOOD
IF23.1
err2024-11-05
err1
PREAI
errMascarenhas, John O.; Rampal, Raajit; El Chaer, Firas; Gupta, Vikas; Shimoda, Kazuya; Kiladjian, Jean-Jacques; Passamonti, Francesco; Bose, Prithviraj; Scandura, Joseph M.; Mesa, Ruben; Rein, Lindsay A. M.; Yuda, Junichiro; Ross, David M.; Devos, Timothy; Talpaz, Moshe; Hoffman, Ronald; Kabir, Sujan; Li, Zhonggai; Foulks, Jason M.; Ansaldo, Karen; Seki, Masataka; Peddagali, Vishnu; Shah, Jatin; Harrison, Claire
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
H
Hagop M. Kantarjian
H 指数: 230 · 论文数: 5.5K
M
Michael R. Stratton
H 指数: 179 · 论文数: 644
P
P. Andrew Futreal
H 指数: 159 · 论文数: 1.3K
P
Peter J. Campbell
H 指数: 159 · 论文数: 747
A
Ayalew Tefferi
H 指数: 152 · 论文数: 2.1K
查看更多